Research Article
Volume 11 Issue 4 - 2022
Malondialdehyde and Haptoglobin among Sickle Cell Disease Children in Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria
Osaro Erhabor1*, Nma Muhammed Jiya2, Murtala Bello Abubakar3 and Sadiya Usman1
1Department of Haematology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria
2Department of Paediatrics, Usmanu Danfodiyo University, Teaching Hospital Sokoto, Sokoto, Nigeria
3Department of Physiology, Faculty of Basic Medical Sciences, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria
4Medical Laboratory Science Council of Nigeria, Abuja
*Corresponding Author: Osaro Erhabor, Department of Haematology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria.
Received: February 21,2022; Published: March 31, 2022


Objectives: Sickle Cell Disease (SCD) is global public health problem. The disease is characterized by free radical associated oxidative stress. This study investigated the malondialdehyde (MDA) and haptoglobin (Hp) levels among children with SCD in Sokoto, Nigeria.

Methods: This study investigated the serum malondialdehyde (MDA) and haptoglobin (Hp) levels among 60 children with SCD. The subjects for this study were categorized into two groups; those in the steady state A (n = 30) and those presenting with vaso- occlusive crisis (VOC) B (n = 30). Twenty-two age-matched non- SCA children served as control (C).

Results: The Hp was significantly lower among the sickle cells subjects compared to controls (p = 0.00) while the MDA level was significantly higher among the SCD subjects compared to controls (p = 0.00). The result showed a statistically significant difference between the MDA and Hp levels of group A versus C (p = 0.000 and 0.011) and B versus C groups (p = 0.000). We did not observe a statistically significant difference between A versus B group (p > 0.05). The effect of age on the MDA and Hp among sickle cell disease children was compared. Age did not have a statistically significant effect on the MDA and Hp levels of the sickle cell subjects (p=0.191 and 0.520) respectively. There was no statistically significant difference in the MDA and Haptoglobin level among sickle cell disease subjects based on gender (p = 0.948 and 0.423) respectively. Ethnicity, maternal occupational group and income level had no statistically significant effect on the MDA and Haptoglobin level among sickle cell disease subjects (p > 0.05).

Conclusion: The finding from this study indicates that SCD subjects tend to have lower values of Hp and higher values of MDA compared to controls. Strategies using antioxidants and therapeutic haptoglobin to protect against plasma lipid oxidation by cell-free haemoglobin may reduce the deleterious effects of lysis-associated cell-free Hb seen in SCD.


Keywords: Malondialdehyde; Haptoglobin; Children; SCD; UDUTH; Sokoto; Nigeria


  1. KA Anie., et al. “Psychosocial impact of sickle cell disorder: perspectives from a Nigerian setting”. Globalization and Health3 (2010): 2.
  2. World Health Organization. Sickle cell anaemia. Report by the secretariat. Fifty-ninth World Health Assembly (2006).
  3. AD Adekile., et al. “Haemoglobinopathies”. In: Azubuike, J.C. and Nkangenieme, K.E.O (Editions), Textbook of Pediatrics and Child Health in a Tropical Region. 3rd edition: African Educational Services (2016): 1053.
  4. NN Jiya., et al. “Sickle Cell Anaemia: A prevalence study among the children attending Usmanu Danfodiyo University Teaching Hospital, Sokoto, North Western Nigeria”. Asian Journal of Medicine and Health2 (2017): 1-8.
  5. B Modell and M Darlison. “Global epidemiology of haemoglobin disorders and derived service indicators”. Bulletin of the World Health Organization 86 (2008): 480-487.
  6. J Makani., et al. “Sickle cell disease in Africa: burden and research priorities”. Annals of Tropical Medical Parasitology 101 (2007): 3-14.
  7. BP Inusa., et al. “Sickle Cell Disease Screening in Northern Nigeria: The Co- Existence of Β- Thalassemia Inheritance”. Pediatrics and Therapeutics 5 (2015): 262.
  8. AF Muinah. “Adherence to Self-Care Management of Sickle Cell Disease among Caregivers”. Walden University Scholar Work (2016).
  9. MA Lamia., et al. “Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia”. Qatar Journal of Medicine 14 (2015): 3- 8.
  10. F Yang., et al. “Pulmonary expression of the human haptoglobin gene”. American Journal of Respiratory and Cellular Molecular Biology 23 (2000): 277-282.
  11. N Pelletier., et al. “Activation of haptoglobin gene expression by cAMP involves CCAAT/enhancer-binding protein isoforms in intestinal epithelial cells”. FEBS Letters 439 (1998): 275-280.
  12. JD'Armiento., et al. “Tissue, temporal and inducible expression pattern of haptoglobin in mice”. Gene 195 (1997): 19-27.
  13. JD Belcher., et al. “Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction”. PLoS One4 (2018): e0196455.
  14. Z Hrkal., et al. “Transfer of heme from ferrihemoglobin and ferrihemoglobin isolated chains to hemopexin”. European Journal of Biochemistry 1 (1974): 73-78.
  15. A Smith and RJ McCulloh. “Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders”. Frontiers in Physiology 6 (2015): 187.
  16. JH Baek., et al. “Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy”. Journal of Clinical Investigation 4 (2012): 1444-1458.
  17. JD Belcher., et al. “Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease”. Blood3 (2014): 377-390.
  18. GM Vercellotti., et al. “Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease”. Molecular Medicine (2016): 22.
  19. RP Santiago., et al. “Serum Haptoglobin and Hemopexin Levels in Pediatric SS and SC Disease Patients: Biomarker of Hemolysis and Inflammation”. Blood22 (2016): 3649.
  20. BD Darcielle., et al. “Evaluation of the concentration of malondialdehyde and nitrite in patients with sickle cell anemia treated or not with hydroxyurea”. Einstein4 (2010): 13.
  21. S Metkari., et al. “An estimation of serum malondialdehyde, superoxide dismutase and Vitamin A in oral submucous fibrosis and its clinicopathologic correlation”. Journal of Oral and Maxillofacial Pathology 11 (2007): 23-27.
  22. S Baliga., et al. “Estimation of malondialdehyde levels in serum and saliva of children affected with sickle cell anemia”. Journal of Indian Society of Pedodontics and Preventive Dentistry 36 (2018): 43-47.
  23. NPC/FRN. “Nigeria population commission Federal Republic of Nigeria”. Special FGN Gazette no. 23 on the 2006 population census (2007).
  24. MA Pourhoseingholi., et al. “Sample size calculation in medical studies”. Gastroenterology and Hepatology from Bed to Bench 1 (2013): 14-17.
  25. DR Janero. “Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury”. Free Radical Biology and Medicine 6 (1990): 515-540.
  26. J Vicky., et al. “Oxidative profile of sickle cell patients in a Cameroonian urban hospital”. BMC Clinical Pathology 16 (2016): 15.
  27. B Sumitra., et al. “Oxidative Stress in Sickle Cell Disease - A Tertiary Hospital Experience in Western Odisha”. International Journal of Medical Science and Public Health8 (2014): 970.
  28. AM Emokpae., et al. “Antioxidant Enzymes and Acute Phase Proteins Correlate with Marker of Lipid Peroxide in Adult Nigerian Sickle Cell Disease Patients”. Iranian Journal of Basic Medical Sciences4 (2010): 177-182.
  29. CP Okorie., et al. “Assessment of Some Indicators of Oxidative Stress in Nigerian Sickle Cell Anemic Patients”. Annals of African Medicine1 (2018): 23-24.
  30. J Titus., et al. “Pro-oxidant and anti-oxidant status in patients of sickle cell anemia”. Indian Journal of Clinical Biochemistry 19 (2004): 168-172.
  31. AI Alsultan., et al. “Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease”. European Review for Medical and Pharmacological Sciences 14 (2010): 527-538.
  32. M Vanusa., et al. “Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients”. Cell Biochemistry and Function Banner5 (2010): 360-366.
  33. A Yalamanoglu., et al. “Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease”. The American Journal of Physiology-Lung Cellular and Molecular Physiology 5 (2018): L765-L774.
  34. U Muller-Eberhard., et al. “Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases”. Blood 32 (1968): 811-815.
  35. JD Belcher., et al. “Transgenic sickle mice have vascular inflammation”. Blood 101 (2003): 3953-3959.
  36. E Nagababu., et al. “Heme degradation and oxidative stress in murine models for haemoglobinopathies: Thalassemia, sickle cell disease and hemoglobin C disease”. Blood Cells, Molecules and Diseases 41 (2008): 61-66.
  37. V Jeney., et al. “Pro‐oxidant and cytotoxic effects of circulating heme”. Blood 100 (2002): 879-887.
  38. SA Akohoue., et al. “Energy expenditure, inflammation, and oxidative stress in steady‐state adolescents with sickle cell anemia”. Pediatric Research 61 (2007): 233-238.
  39. KA Nath., et al. “Transgenic sickle mice are markedly sensitive to renal ischemia‐reperfusion injury”. The American Journal of Pathology 166 (2005): 963-972.
  40. M Aslan., et al. “Oxygen radical inhibition of nitric oxide‐dependent vascular function in sickle cell disease”. Proceedings of the National Academy of Sciences of the United States of America 98 (2001): 15215-15220.
  41. K Sheng., et al. “Comparative oxidation of haemoglobins A and S”. Blood 91 (1998): 3467-3470.
  42. PS Rayra., et al. “Serum Haptoglobin and Hemopexin Levels in Pediatric SS and SC Disease Patients: Biomarker of Hemolysis and Inflammation”. Blood 128 (2016): 3649.
  43. CB Harrison., et al. “Exploratory Study of Haptoglobin Levels by Genotype in Adult Sickle Cell Patients”. Blood 118 (2011): 2145.
  44. DJ Schaer., et al. “Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins”. Blood 121 (2013): 1276-1284.
  45. DJ Schaer., et al. “Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development”. Frontiers in Physiology 5 (2014): 415.
  46. M Melamed-Frank., et al. “Structure-function analysis of the antioxidant properties of haptoglobin”. Blood13 (2001): 3693-3698.
  47. RP Santiago., et al. “Serum Haptoglobin and Hemopexin Levels in Pediatric SS and SC Disease Patients: Biomarker of Hemolysis and Inflammation”. Blood22 (2016): 3649.
  48. NN Magnun. “Haptoglobin: an emerging candidate for phenotypic modulation of sickle cell anemia?” Brazilian Journal of Haematology and Hemotherapy6 (2015): 361-363.
Citation: Osaro Erhabor., et al. “Malondialdehyde and Haptoglobin among Sickle Cell Disease Children in Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria”. EC Paediatrics 11.4 (2022): 105-116.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 10, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.